Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China

Qiao Liu; Peng Lu; Ye Shen; Changwei Li; Jianming Wang; Limei Zhu; Wei Lu; Leonardo Martinez

doi:10.1093/cid/ciaa1289

Collateral Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Tuberculosis Control in Jiangsu Province, China

Clin Infect Dis. 2021 Aug 2;73(3):542-544. doi: 10.1093/cid/ciaa1289.

Authors

Qiao Liu¹, Peng Lu¹, Ye Shen², Changwei Li^{2

3}, Jianming Wang⁴, Limei Zhu¹, Wei Lu¹, Leonardo Martinez⁵

Affiliations

¹ Department of Chronic Communicable Disease, Center for Disease Control and Prevention of Jiangsu Province, Nanjing, China.
² University of Georgia, College of Public Health, Department of Epidemiology and Biostatistics, Athens, Georgia, USA.
³ Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
⁴ Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
⁵ Stanford University, School of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, USA.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic may impede global tuberculosis elimination goals. In Jiangsu Province, China, tuberculosis notifications dropped 52% in 2020 compared to 2015-2019. Treatment completion and screening for drug resistance decreased continuously in 2020. Urgent attention must be paid to tuberculosis control efforts during and after the COVID-19 pandemic.

Keywords: COVID-19; China; drug resistance; tuberculosis.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
China / epidemiology
Humans
Pandemics
SARS-CoV-2
Tuberculosis* / epidemiology